Brivaracetam inhibits spreading depression in rat neocortical slices in vitro

Seizure

Volumn 18, Issue 6, 2009, Pages 453-456

  Margineanu, Doru Georg ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Brivaracetam; Cortical spreading depression; Levetiracetam; Migraine prophylaxis

Indexed keywords

BRIVARACETAM; ETIRACETAM; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; IN VITRO STUDY; MALE; MICROELECTRODE; MICROPIPETTE; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEOCORTEX; PIRACETAM; POTASSIUM CHLORIDE; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; SPREADING CORTICAL DEPRESSION;

EID: 67349097383     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.01.002     Document Type: Article

References (26)

1. De Simone R., Ranieri A., Marano E., Beneduce L., Ripa P., Meo R., et al. Migraine and epilepsy: clinical and pathophysiological relations. Neurol Sci 28 (2007) S150-S155
2. Editorial J.A.M.A., and Migraine epilepsy. J Am Med Assoc 30 (1898) 869-870 [Reprinted in 1998;279:1126]
3. Haut S.R., Bigal M.E., and Lipton R.B. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 5 (2006) 148-157
4. Calabresi P., Galletti F., Rossi C., Sarchielli P., and Cupini L.M. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol Sci 28 (2007) 188-195
5. Pietrobon D., and Striessnig J. Neurobiology of migraine. Nat Rev Neurosci 4 (2003) 386-398
6. Hadjikhani N., Sanchez del Rio M., Wu O., Schwartz D., Bakker D., Fischl B., et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98 (2001) 4687-4692
7. Anderson T.R., and Andrew R.D. Spreading depression: imaging and blockade in the rat neocortical brain slice. J Neurophysiol 88 (2002) 2713-2725
8. Gorji A., Scheller D., Straub H., Tegtmeier F., Köhling R., Höhling J.M., et al. Spreading depression in human neocortical slices. Brain Res 906 (2001) 74-83
9. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., and Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8 (2002) 136-142
10. Welch K.M. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 45 Suppl. 1 (2005) S25-S32
11. Akerman S., and Goadsby P.J. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. NeuroReport 12 (2005) 1383-1387
12. Ayata C., Jin H., Kudo C., Dalkara T., and Moskowitz M.A. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59 (2006) 652-661
13. Kenda B.M., Matagne A.C., Talaga P.E., Pasau P.M., Differding E., Lallemand B.I., et al. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem 47 (2004) 530-549
14. Matagne A., Margineanu D.G., Kenda B., Michel P., and Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein SV2A. Br J Pharmacol 154 (2008) 1662-1671
15. von Rosenstiel P. Brivaracetam (UCB 34714). Neurotherapeutics 4 (2007) 84-87
16. Margineanu D.G., and Klitgaard H. The connexin 36 blockers quinine, quinidine and mefloquine inhibit cortical spreading depression in a rat neocortical slice model in vitro. Brain Res Bull 71 (2006) 23-28
17. + currents in rat cortical neurons in culture. Epilepsia 45 Suppl. 7 (2004) 146
18. Margineanu D.G., and Klitgaard H. Inhibition of neuronal hyper-synchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 42 (2000) 281-285
19. Nagarkatti N., Deshpande L.S., and DeLorenzo R.J. Levetiracetam inhibits both ryanodine and IP3 receptor activated calcium induced calcium release in hippocampal neurons in culture. Neurosci Lett 436 (2008) 289-293
20. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
21. Bigal M.E., Lipton R.B., Cohen J., and Silberstein S.D. Epilepsy and migraine. Epilepsy Behav 4 (2003) S13-S24
22. Ludvigsson P., Hesdorffer D., Olafsson E., Kjartansson O., and Hauser W.A. Migraine with aura is a risk factor for unprovoked seizures in children. Ann Neurol 59 (2006) 210-213
23. Frediani F. Anticonvulsant drugs in primary headaches prophylaxis. Neurol Sci 25 (2004) S161-S166
24. Marrannes R., De Prins E., Fransen J., and Clincke G. Neuropharmacology of spreading depression. In: Lehmenkühler A., Grotenmeyer K.H., and Tegtmeier F. (Eds). Migraine: basic mechanisms and treatment (1993), Urban & Schwarzenberg, München, Germany 431-443
25. Klitgaard H., and Verdru P. Levetiracetam: the first SV2A ligand for the treatment of epilepsy. Expert Opin Drug Disc 2 (2007) 1537-1545
26. 2+ currents. Seizure 10 (2001) 279-286